Catalyst Wire Dossier Catalyst Wire Dossier

Sonelokimab

sonelokimab · MoonLake Immunotherapeutics AG
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Sonelokimab, covering 2024-05-03 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

See pricing